Oric Pharmaceuticals
ORIC
ORIC
182 hedge funds and large institutions have $1.51B invested in Oric Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 57 increasing their positions, 63 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
8% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $959K
10% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 63
3.93% less ownership
Funds ownership: 122.86% → 118.93% (-3.9%)
Holders
182
Holding in Top 10
7
Calls
$1.04M
Puts
$959K
Top Buyers
| 1 | +$27.9M | |
| 2 | +$23.8M | |
| 3 | +$22.6M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$12.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$11.4M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$15.4M | |
| 3 | -$10.8M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$8.49M |
| 5 |
Barclays
London,
United Kingdom
|
-$8.02M |
